Answers are grounded in this paper and cite their sources.
Findings demonstrate treatment persistence of interleukin-17 and interleukin-23 inhibitors in plaque psoriasis, suggesting implications for clinical decision-making.
These findings may inform clinical decision-making by healthcare providers, patients, and policymakers. Further research integrating richer clinical information with extended follow-up will allow deeper investigation of biologic treatment patterns in real‑world settings.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: